Tendency to Suicide as a Sequel of Computer Vision Syndrome
Prevalence and Associated Risk Factors of Tendency to Suicide as a Sequel of Computer Vision Syndrome Among Medical Students in Egypt
1 other identifier
observational
3,512
1 country
1
Brief Summary
CVS-F4 questionnaire will be used as an instrument to survey prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2022
CompletedStudy Start
First participant enrolled
October 30, 2022
CompletedFirst Posted
Study publicly available on registry
January 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedMarch 31, 2023
March 1, 2023
4 months
October 9, 2022
March 30, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Tendency to suicide
The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentage of participants suffering from tendency to suicide will be recorded
3 months
Depression
The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentages of participants suffering from tendency to suicide and depression will be recorded. A correlation between depression and tendency to suicide will be measured as P value less than 0.05 will be significant
3 months
Screen-time
The total daily average screen-hours will be measured using mean and standard deviation
3 months
Interventions
CVS-F4 will be an online survey via the SurveyMonkey Company. The participants will report their potential CVS complains and associated screen factors as screen-time, screen-size, screen-resolution and other factors. We will collect the responses and analyse the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. This group will contain participants with CVS complains. Finally, we will To document the prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents.
Eligibility Criteria
medical students or staff who are using screens in their medical studies or personal lives and how these screens affect their medical studies and the effect of mandated medical computer use if present on their screen-behaviour, tendency to suicide and associated risk factor
You may qualify if:
- university students
- university staff members
You may not qualify if:
- hysteria
- ocular surgery
- amblyopia
- anisometropia
- strabismus
- systemic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Faculty of medicine
Sohag, 82425, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammed Iqbal Iqbal, MD, PhD
Professor of Ophthalmology
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Ophthalmology
Study Record Dates
First Submitted
October 9, 2022
First Posted
January 26, 2023
Study Start
October 30, 2022
Primary Completion
February 20, 2023
Study Completion
March 30, 2023
Last Updated
March 31, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- 12 months
The study data will available at the principal investigator for other researchers upon reasonable request after publication of the study